BiomX Inc.
General ticker "PHGE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $33.5M (TTM average)
BiomX Inc. does not follow the US Stock Market performance with the rate: -14.0%.
Estimated limits based on current volatility of 5.8%: low 4.25$, high 4.77$
Factors to consider:
- Total employees count: 54 as of 2022
- Top business risk factors: Regulatory and compliance, Market competition, Early stage company risks, Organizational growth, Intellectual property risks
- Current price 82.5% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [37.69$, 104.61$]
- 2024-12-30 to 2025-12-30 estimated range: [27.33$, 79.92$]
Financial Metrics affecting the PHGE estimates:
- Positive: with PPE of -0.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.33 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0.84
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: 0.79 < Interest expense per share per price, % of 1.62
Short-term PHGE quotes
Long-term PHGE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $35.46MM | $27.22MM | $25.35MM |
| Operating Income | $-35.46MM | $-27.22MM | $-25.35MM |
| Non-Operating Income | $-0.70MM | $-1.03MM | $-0.80MM |
| Interest Expense | $0.70MM | $2.07MM | $2.40MM |
| R&D Expense | $22.68MM | $16.24MM | $16.70MM |
| Income(Loss) | $-36.16MM | $-28.25MM | $-26.15MM |
| Taxes | $0.07MM | $0.07MM | $0.02MM |
| Profit(Loss)* | $-36.23MM | $-28.32MM | $-26.17MM |
| Stockholders Equity | $47.53MM | $21.04MM | $3.08MM |
| Assets | $77.99MM | $45.53MM | $25.03MM |
| Operating Cash Flow | $-27.57MM | $-29.09MM | $-21.29MM |
| Capital expenditure | $3.68MM | $0.11MM | $0.05MM |
| Investing Cash Flow | $16.17MM | $-2.11MM | $1.95MM |
| Financing Cash Flow | $37.28MM | $0.29MM | $2.90MM |
| Earnings Per Share** | $-1.39 | $-0.95 | $-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.